Skip to main content
Download PDF

Proteomic analysis of Rickettsia akari proposes a 44 kDa-OMP as a potential biomarker for Rickettsialpox diagnosis

BMC Microbiology volume 20, Article number: 200 (2020) Cite this article

Abstract

Background

Rickettsialpox is a febrile illness caused by the mite-borne pathogen Rickettsia akari. Several cases of this disease are reported worldwide annually. Nevertheless, the relationship between the immunogenicity of R. akari and disease development is still poorly understood. Thus, misdiagnosis is frequent. Our study is aiming to identify immunogenic proteins that may improve disease recognition and enhance subsequent treatment. To achieve this goal, two proteomics methodologies were applied, followed by immunoblot confirmation.

Results

Three hundred and sixteen unique proteins were identified in the whole-cell extract of R. akari. The most represented protein groups were found to be those involved in translation, post-translational modifications, energy production, and cell wall development. A significant number of proteins belonged to amino acid transport and intracellular trafficking. Also, some proteins affecting the virulence were detected. In silico analysis of membrane enriched proteins revealed 25 putative outer membrane proteins containing beta-barrel structure and 11 proteins having a secretion signal peptide sequence. Using rabbit and human sera, various immunoreactive proteins were identified from which the 44 kDa uncharacterized protein (A8GP63) has demonstrated a unique detection capability. It positively distinguished the sera of patients with Rickettsialpox from other rickettsiae positive human sera.

Conclusion

Our proteomic analysis certainly contributed to the lack of knowledge of R. akari pathogenesis. The result obtained may also serve as a guideline for a more accurate diagnosis of rickettsial diseases. The identified 44 kDa uncharacterized protein can be certainly used as a unique marker of rickettsialpox or as a target molecule for the development of more effective treatment.

Background

From the clinical and antigenic perspective, Rickettsia species (Order Rickettsiales, Family Rickettsiaceae) are obligate intracellular gram-negative alpha-proteobacteria that diverged into three major phylogenetic groups [1,2,3]. This includes the typhus group (TG), spotted fever group (SFG), and the transitional group of Rickettsia (TRG). Rickettsia akari, the causative agent of Rickettsialpox, was originally classified into the SFG. However, current genomic studies suggested placing this organism together with R. australis and R. felis into the TRG [4, 5]. This pathogen is usually transmitted to humans and animals by the rodent mites Liponyssoides sanguineus [6, 7]. Nevertheless, it was also detected in the mite Leptotrombidium scutellare [8] and Korean voles Microtus fortis pelliceus [9]. Rickettsialpox was first described in New York City in 1946 [10] and has been since reported in diverse parts of Europe, Asia and North America [11,12,13,14,15,16]. Patients suffering from this illness describe fever, headache, lymphadenopathy, myalgia, and eschar at the site of the mite bite. Early in the febrile course of the disease, a maculopapular eruption with intraepidermal vesicles usually appears, sparing the palms and soles of the feet [17]. But due to similar symptoms, it is often confused with cutaneous anthrax or smallpox [18, 19]. Thus, it was recommended to confirm the clinical observations with serological testing. Although a high level of cross-reactivity in antibody responses is noted between R. akari and other rickettsiae from the Spotted fever group [20].

Rickettsia species possess a relatively small genome (1.1 to 1.3 Mb) compared to those of their free-living relatives. Particularly, the complete genome sequence of R. akari comprises 1.23 megabase pairs containing 1013 protein-coding genes, 274 pseudogenes, and 39 RNA genes (gene bank accession No. CP000847). This feature is a consequence of invariable genome reduction caused by specialization to a restricted set of hosts during adaptation to the parasitic lifestyle [21]. Further analysis of rickettsial genomes, including R. akari, showed a number of split genes and palindromic elements inserted into genes [2]. Some data are also available from proteomic investigations of Rickettsia species [22,23,24,25,26,27]. The majority of identified proteins play a crucial role in the mechanism of pathogenesis and virulence of the bacteria. Proteins, however, may also act in antibiotic resistance [28] and host-specific immune response. Recent investigations on rickettsia-host interactions have also identified several important proteins involved in rickettsial adhesion and/or invasion as well as activation of host-cell signaling [29].

In this study, we investigated the antigenic potential of R. akari proteins using gel-free and gel-based proteomic approaches coupled to Liquid Chromatography-Mass Spectrometry (LC-MS/MS) experiments. Particular interest was paid on immunodominant cell envelope associated proteins. These key antigens might represent targets for novel diagnostics or vaccine development.

Results

Identification of rickettsial proteins using gel-free and gel-based proteomic approaches

Using two independent proteomics approaches, we identified 288 R. akari proteins in the whole bacterial lysate, from which 39 were identified as uncharacterized proteins. The identified proteins were ranging from 5.2 to 214 kDa in molecular mass and from 4.4 to 13.0 in isoelectric points. Out of these 288 proteins, 41 proteins were identified with predicted molecular masses higher than 70 kDa, 127 proteins with predicted molecular masses between 30 to 70 kDa, and 120 proteins with predicted molecular masses lower than 30 kDa. The sequence coverage of the identified proteins ranged from 1.2% (A8GLW4 – cell surface antigen) to 76.8% (A8GPB6–60 kDa chaperonin GroEL), and the abundance values expressed in label-free quantification (LFQ) ranged from 35.8 (A8GPB6–60 kDa chaperonin GroEL) to 21.5 (A8GPP7 - aspartokinase), with an average value of 26.4 (Additional file 1).

The detected R. akari proteins were grouped into 25 distinct Clusters of Orthologous Groups (COGs), using the database EggNOG v5.0 (http://eggnog5.embl.de/#/app/home). According to this classification, 27.4% of proteins are involved in translation, ribosomal structure, and biogenesis (COG: J); 9% in energy production and conversion (COG: C); 8.3% in cell wall/membrane/envelope biogenesis (COG: M); 6.9% in posttranslational modification, protein turnover, and chaperones (COG: O); 5.6% in intracellular trafficking, secretion, and vesicular transport (COG: U); 4.5% in amino acid transport and metabolism (COG: E); 4.2% in transcription (COG: K) 9.4% with unknown function (COG: S) and 3.5% non-belong to orthologous group (NOG). The remaining 21.2% of proteins belong to 17 other COGs (A, CO, D, F, FG, FP, G, H, I, IQ, L, MU, OU, P, PQ, T, V) in the share of 0.3 to 2.8% (Fig. 1).

Fig. 1
figure1

R. akari identified proteins assigned to their COGs. The pie chart shows the functional distribution of detected proteins by the EggNOG v5.0 database. The percentages of proteins in each COG category are indicated

Full size image

Surface-exposed and envelope associated proteins (SEPs)

SEPs of R. akari represent an essential interface in pathogen-host interactions. To recognize these proteins, two membrane-enriched rickettsial extracts were prepared as detailed in the materials and method section. In the first, the cell-impermeant reagent, Sulfo-NHS-LC-Biotin, was used to label SEPs. The biotinylated proteins were then isolated by streptavidin agarose affinity purification. On the other hand, the second protocol was based on the Triton X-114 phase partitioning. This non-ionic detergent substitutes the lipid molecules interacting with the hydrophobic domain of integral membrane proteins and forms soluble protein–detergent micelles. After temperature changes, phase separation occurs. Hydrophobic proteins aggregate in the detergent phase, while the hydrophilic remain in the aqueous layer [30]. All the obtained fractions were then separated by 12% SDS-PAGE and analyzed with LC-MS/MS. Using these approaches¸ we identified 83 unique R. akari proteins with molecular masses range from 5.5 to 168.0 kDa and pI from 4.6 to 12.1. Fourteen of these proteins were recognized with both approaches, including OmpB (A8GPL7), chaperone protein DnaK (A8GMF9), 60 kDa chaperonin GroEL (A8GPB6), ATP synthase subunit alpha (A8GPZ6), a 44 kDa uncharacterized protein (A8GP63), superoxide dismutase (A8GNP0), putative adhesin A1C_06425 (A8GQ33), thioredoxin peroxidase 1 (A8GN15), inorganic pyrophosphatase (A8GP57), stress-induced DNA-binding protein (A8GPZ9), nucleoside diphosphate kinase (A8GLZ8), 50S ribosomal protein L7/L12 (A8GMA6), 10 kDa chaperonin (A8GPB7) and 7 kDa uncharacterized protein (A8GNR0).

Out of the 83 identified proteins, 15 were predicted using the PSORTb prediction tool [31] as a membrane or secreted extracellular proteins (Fig. 2a, Table 1), 1 protein as periplasmic, 48 proteins as cytoplasmic, and 17 proteins with unknown followed by 2 with multiple localizations. Using the SOSUIgramN program [32], 20 proteins were anticipated as a membrane or extracellular (Fig. 2a, Table 1), 2 proteins as periplasmic, 57 proteins as cytoplasmic and 4 proteins with unknown locations. In addition, the PRED-TMBB online tool [33] recognized 25 proteins with beta-barrel structure (Fig. 2a, Table 1), and 11 proteins were predicted with the Signal P–5.0 server to possess a signal peptide at the N-terminus (Fig. 2a, Table 1). Interestingly, nine of these proteins apparently carry a Type I secretory signal peptides that are usually transported by the Sec or twin-arginine translocon (Tat). These proteins include the OmpB (A8GPL7), 44 kDa uncharacterized protein (A8GP63), putative adhesin A1C_06425 (A8GQ33), putative surface antigen (A8GM15), 19 kDa uncharacterized protein (A8GP34), 17 kDa uncharacterized protein (A8GPM2), tail-specific protease (A8GMM4), protein export protein PrsA (A8GP43), and the 18 kDa uncharacterized protein (A8GNE2). Additional two proteins, namely 9 kDa uncharacterized protein (A8GNC4) and a peptidoglycan-associated lipoprotein (A8GPW0), were predicted to have a lipoprotein signal peptides suggesting Type II secretion.

Fig. 2
figure2

R. akari SEPs detected in the membrane enriched fractions. (a) Venn diagram of proposed SEPs using four different prediction tools. (b) Pie chart illustrating the distribution of R. akari SEPs identified in membrane protein-enriched fractions among the COGs

Full size image
Table 1 Surface exposed proteins of R. akari
Full size table

Using the four bioinformatics algorithms, we suggested 33 proteins with predicted outer membrane localization or possessing signal peptides or beta-barrel structure as R. akari SEPs (Table 1). These proteins were then grouped into 8 distinct COGs, using the database EggNOG v5.0. According to this classification, 18.2% of proteins are involved in posttranslational modification, protein turnover, and chaperones (COG: O); 15.2% with unknown function (COG: S); 12.1% in cell wall/membrane/envelope biogenesis (COG: M); 12.1% in energy production and conversion (COG: C); 12.1% in amino acid transport and metabolism (COG: E); 9.1% of proteins are involved in translation, ribosomal structure, and biogenesis (COG: J). The remaining 6% of proteins belong to 2 other COGs (D and P) in the share of 3% each (Fig. 2b, Additional file 2). Five proteins were not classified into any clusters of orthologous groups due to unknown functions.

Immunogenic SEPs

In order to identify antigenic proteins, the 2-dimensional electrophoresis (2-DE, Fig. 3a) of the whole R. akari cell extract were probed against the anti - R. akari polyclonal rabbit serum (Fig. 3b) and the serum of infected patient clinically diagnosed with rickettsialpox (Fig. 3c). From the identified immunoreactive proteins, five were recognized in this study as SEPs, namely a 60 kDa chaperonin GroEL (A8GPB6), OmpB (A8GPL7), DnaK (A8GMF9), Peptidoglycan-associated lipoprotein (A8GPW0), and a 44 kDa uncharacterized (A8GP63) protein.

Fig. 3
figure3

Immunogenic SEPs of R. akari. (a) R. akari proteins (140 μg) from whole-cell extract separated by 2-DE. 1- OmpB (A8GPL7), 2 - chaperon protein DnaK (A8GMF9), 3–60 kDa chaperonin GroEL (A8GPB6), 4–44 kDa uncharacterized protein (A8GP63), 5 – peptidoglycan associated lipoprotein (A8GPW0), 6 – superoxide dismutase (A8GNP0) (b) 2-D Western blot analysis of R. akari proteins using serum from infected rabbit (1:1000) (c) or infected patient’s serum (1:1000) (d) SDS-PAGE of selected SEPs prepared with recombinant technology. L: protein marker; lane 1–44 kDa uncharacterized protein (A8GP63) (3 μg); 2–60 kDa chaperonin GroEL (8 μg); 3- chaperon protein DnaK (6 μg). (e) Western blot analyses of recombinant (2 μg per lane) 44 kDa uncharacterized protein (lanes 1–7), 60 kDa chaperonin GroEL (lanes 8–14), and chaperon protein DnaK (lanes 15–21) probed against - 1-2, 8–9, 15–16: sera of healthy donors (negative controls, 1:1000); 3–5, 10–12, 17–19: sera of Rickettsialpox patients (1:1000), and 6–7, 13–14, 20–21: sera of patients with SFG rickettsial infection (1:1000)

Full size image

The 44 kDa uncharacterized protein (A8GP63) together with the highly abundant 60 kDa (GroEL) (A8GPB6) and the DnaK (A8GMF9) were prepared by ectopic expression in E.coli BL21(DE3). Purified recombinant proteins were then separated by SDS-PAGE (Fig. 3d) and probed against five sera from patients with confirmed rickettsial infection (2 sera of patients with SFG rickettsiosis and 3 with Rickettsialpox) (Fig. 3e). Interestingly, the proteins GroEL and DnaK reacted with all the patient’s sera. However, the 44 kDa uncharacterized protein (A8GP63) conducted a response only with the sera of patients suffering from Rickettsialpox (Fig. 3e, lanes 3, 4, 5). No reactivity was observed with the sera of patients with SFG rickettsiosis. In this protein preparation, two bands (about 44 kDa and 22 kDa) were seen in the SDS-PAGE and the immunoblots. However, both correspond to the 44 kDa uncharacterized protein as determined by LC-MS /MS analysis. The lower and upper ones represent the truncated and full-length protein, respectively (Fig. 3c).

Characterization of the 44 kDa uncharacterized protein (A8GP63)

The homology searches for the R. akari putative 44 kDa uncharacterized protein against the NCBI database showed high identity (91.8%) to uncharacterized protein from R. australis and 83.2% to unknown protein (RF_0375) from R. felis (accession number AAY61226.1). However, only a low level of sequence similarity and protein size was noted in the comparison to other SFG rickettsiae (e.g., R. conorii (AAL03440.1), R. parkeri (WP_146709264.1), R. slovaca (WP_041472097.1), R. rickettsii (WP_041472549.1) (Fig. 4a). Such a drift usually occurs due to gene loss which is a major source of genome diversification within Rickettsia species and may reflect host specialization to distinct arthropods [16].

Fig. 4
figure4

The 44 kDa protein (A8GP63) of R. akari as an outer membrane protein. (a) Homology search to 44 kDa protein using blast analysis (b) In silico prediction of the protein secondary structure (c) IFA using a “pre-absorbed” mouse polyclonal antibody against the 44 kDa protein

Full size image

Based on precise bioinformatics predictions, we could suggest that this 44 kDa protein is having a Sec signal peptide (Sec/SPI) and secondary transmembrane structure (Fig. 4b) that is represented by beta-barrels typical for outer membrane proteins. The protein structure also showed a high percentage of total accessible surface area that could be easily available for antibody binding. Using the B-cell type epitope predictor, we revealed the candidate epitopes for the 44 kDa uncharacterized protein (A8GP63). We found 10 potential peptides that showed a score higher than the cut-off. Six of them were exposed on the protein surface and probably well available for antibody binding (Additional file 3). Thus, this observation may suggest that the R. akari protein can be involved in the specific interaction with the host cell.

To confirm surface localization of this protein we performed a dual immunofluorescence antibody assay. For this purpose, we developed a mouse polyclonal antibody against the 44 kDa uncharacterized protein and conjugated it with Alexa 488 which provides a green fluorescence signal. In order to significantly reduce cross-reactivity and to increase the specificity of protein recognition, we pre-absorbed the mouse serum with E. coli cells prior to immunofluorescence assay (IFA). As seen in Fig. 4c, the green fluorescence signal is apparently associated with the outer membrane of R. akari. We observed a robust protein accumulation clustering near the pole of rickettsial cells. Such a feature was also recorded for surface cell antigens (Sca) of R. typhi, including Sca2, Sca3, and Sca4, as seen in immunoelectron microscopy where clustering of Sca proteins on the surface of intact rickettsia was clearly demonstrated [34].

Discussion

In this work, a comprehensive proteomic study of R. akari was performed using gel-based and gel-free approaches with the aim to identify proteins having a key role in pathogen-host interactions. In the first step, proteins from the whole-cell extract of the bacterium were separated by 2-DE. In the gel (Fig. 3a), 356 protein spots were detected. The spots were excised and identified by ESI-LC-MS/MS mass spectrometry. Obtained data were then combined with protein identification from a gel-free (shotgun) proteomic approach that was based on LC-MS/MS analyses. These proteomic analyses resulted in the identification of 288 unique proteins that correspond to 28.4% of 1013 protein-coding genes annotated in the R. akari genome. Similar numbers of proteins were identified in previous proteomic studies in which R prowazekii, R. conori, R. raoultii, R. massiliae, R. slovaca, and R. parkeri were evaluated [22, 24,25,26, 35].

The largest group of identified proteins was associated with translation, ribosomal structure, and biogenesis. This group was tightly followed by enzymes involved in the processes of central metabolic pathways such as glycolysis, pentose phosphate pathway, tricarboxylic acid (TCA) cycle, oxidative phosphorylation, fatty acid metabolism, and amino acid metabolism. Four key enzymes of TCA cycle, which have been shown to be complete in Rickettsiae (KEGG, MAP 00020) were detected in this study, namely malate dehydrogenase (A8GN82) citrate synthase (A8GQ56), acetyltransferase component of pyruvate dehydrogenase complex (A8GNQ3), and 2 subunits (alpha and beta) of pyruvate dehydrogenase E1 component (A8GMR3 and A8GMR4 respectively). Despite the evidence of a functional presence of pyruvate dehydrogenase complex and TCA cycle, it was shown that Rickettsia spp. cannot metabolize (glycolysis) or generate (gluconeogenesis) glucose [36]. Neither pyruvate can be synthesized due to the lack of metabolic pathways necessary for pyruvate synthesis [37]. Therefore, glucose and pyruvate should be uptaken directly or in the form of phosphoenolpyruvate from the host cells cytoplasm to support ATP generation via the TCA cycle [23]. In this case, phosphoenolpyruvate is converted to pyruvate by pyruvate phosphate dikinase (A8GNN4), which was detected in this study. Nevertheless, ATP can be synthesized by oxidative phosphorylation. The presence of four ATP synthase subunits (A8GPZ3, A8GPZ4, A8GPZ6, A8GPZ7) illustrates the importance of this pathway in Rickettsiae that is necessary to compensate for glycolysis defect [23].

In addition to exogenous uptake of major energy sources including glucose, ATP and NAD+ [36], Rickettsiae as intracellular organisms possess refined secretion mechanisms to translocate various effector proteins into the host cell in order to sustain survival. They are equipped with various types of secretion systems, including the Sec or Tat translocation pathways, type I secretion system (T1SS), type IV secretion system (T4SS), and type V autotransporter pathways (T5SS) [38]. As in earlier rickettsial proteome studies [22, 25], we identified several proteins of Sec-mediated translocation system, namely protein translocase subunit SecD (A8GP54), Sec translocon accessory complex subunit YajC (A8GP53), signal recognition particle receptor FtsY (A8GPW4), preprotein translocase subunit SecG (A8GM25), and a protein-export membrane protein SecG (A8GM27), that is unique to all rickettsiae [23, 25]. We also identified two out of the three major structural features of the T1SS, namely outer membrane efflux protein (A8GMM0) belonging to the TolC family [38] and a putative ABC transporter ATP-binding component (A8GM03). This protein is a constituent of ATP-binding cassette transporters that play a role in multidrug resistance [23, 39]. Moreover, we detected three components of T4SS, namely TrbL/VirB6 plasmid conjugative transfer proteins (A8GM63–67), VirB4 family protein (A8GM62), and VirD4 protein (A8GMV1). The last interact with a VirB4 protein and the ATPases VirB11 independently of other subunits and forms the ATPase complex that dock to the inner membrane. The VirD4 also acts as a receptor that may transport substrates to the translocation channel [40, 41]. Meanwhile, VirB6 is the key polytopic membrane protein forming the inner membrane channel that is essential for substrate secretion (Additional file 1).

Secreted proteins and SEPs play a key role in pathogen-host interactions by allowing infection of the host cell and promoting bacterial replication in the cytosol [34]; hence identification of these important molecules is essential. Obviously, the surface cell antigen (Sca) family proteins are undoubtedly included among the most dominant SEPs which play an important role in rickettsial pathogenesis [42,43,44]. Previous studies indicated that two major Sca proteins, outer membrane protein A (Sca0 or OmpA) and OmpB (Sca5), might play key roles in the adhesion of the Rickettsia cells to the host tissue [42, 44,45,46]. These molecules are likely major antigenic determinants of Rickettsia spp and represent good candidates for vaccine development. Nucleotide sequences of these proteins were even used for phylogenetic determination. While OmpB (A8GPL7) has been identified in several Rickettsia spp. including R. akari (in this study), the presence of OmpA was reported only in the SFG [47]. The latest protein is mostly not encoded in the genomes of TG Rickettsia [34]. Further evaluation of the identified proteins has revealed many similar SEPs as in other Rickettsiae, including the OmpB (A8GPL7), putative adhesin (A8GQ33), heat shock protein (A8GMS9), and chaperone proteins DnaK (A8GMF9) and GroEL (A8GPB6). Using enrichment protocols, we also detected the cell division coordinator CpoB (A8GMM6) surface protein, the TolB protein (A8GMX9), and the actin polymerization protein RickA (A8GP67). The CpoB was previously described as a YbgF protective antigen [27]. Together with TolB, these periplasmic proteins are essential for the Tol-Pal system, which has a role in the maintenance of cell envelope integrity. These proteins may also participate in translocation of virulence factors [48]. On the other hand, the identification of actin polymerization protein RickA (A8GP67), an activator of the host Arp2/3 complex, may indicate the actin-based motility of R. akari [49, 50]. Thus this protein could be proposed as an important factor of virulence in SFG Rickettsia. It promotes spreading among host cells, unlike the Typhus group members [51, 52].

However, the main aim of this study was to investigate the antigenic potential of these important R. akari proteins. For this propose, the whole-cell extract was analyzed using a two-dimensional immunoblot technique coupled to LC-MS/MS identification. Under our experimental conditions, a strong immunological response of R. akari lipopolysaccharide against the polyclonal sera of infected rabbit and positive patient sera was evident. Nevertheless, among the proteins with predicted beta-barrel structure, which were proposed to be R. akari SEPs, we detected only four immunoreactive antigens, namely chaperone proteins GroEL (A8GPB6) and DnaK (A8GMF9), outer membrane protein B (A8GPL7), and an uncharacterized protein (A8GP63). Heat shock proteins GroEL and DnaK are the most frequently detected immunoreactive proteins with high abundance in Ricketssiae, as it was indicated in many previous studies on R. felis, R. conorii, R. helvetica, and R. rickettsii [24, 25, 53]. The upregulation of groEL and dnak was also described in R. prowazekii as a response to heat shock exposure [54]. According to our shotgun label-free proteomic quantitation (LFQ), proteins GroEL and DnaK belong to the most abundant proteins of R. akari, with LFQ values 35.8 and 32.2, respectively, whereas the average value of all identified proteins achieved 26.4. Interestingly, one of the uncharacterized proteins, the 44 kDa uncharacterized protein (A8GP63) also seems to be abundant as it reached the LFQ value of 30.1.

So far, no evidence was published concerning this uncharacterized protein (A8GP63). The protein homology search showed very high sequence similarity with two unknown orthologous proteins from R. australis (H8K6W8) and R. felis (Q4UMI2). However, only a very low similarity was noted to other SFG rickettsiae (Fig. 4a). This is in line with the classification to TRG of Rickettsia since R. akari is phylogenetically related the most closely to R. australis and R. felis [4]. To better describe this unique protein, it was prepared by ectopic expression in E. coli. At the same time, we also produced the highly abundant 60 kDa (GroEL) and 70 kDa (DnaK) of R. akari for comparative purposes. Then, these recombinant proteins were tested against 3 positive sera from Rickettsialpox patients and 2 positive patient sera with spotted fever group rickettsiosis. As we predicted, all positive patient sera distinguished the recombinant proteins GroEL and DnaK. However, the 44 kDa unknown protein was recognized exclusively with the positive sera from Rickettsialpox patients. Moreover, IFA using specific mouse serum against this 44 kDa uncharacterized protein (A8GP63) together with precise bioinformatics suggested membrane association. Thus, the 44 kDa uncharacterized protein (A8GP63) appears to be a valuable biomarker of R. akari.

Conclusions

This paper represents the first comprehensive proteomic study of R. akari that was accomplished using gel-based and gel-free proteomics approaches. Altogether we identified 316 unique proteins that correspond to 31.2% of 1013 protein-coding genes annotated in the R. akari genome. From them, 33 proteins found in the cell envelope enrichment fractions were predicted as outer membrane proteins or proteins possessing a signal peptide or a beta-barrel structure indicating membrane association. These proteins were proposed as R. akari SEPs that may play a key role in pathogen-host interactions. However, antigenic protein seems to be the most important in terms of effective vaccine development and the discovery of new biomarkers for clinical diagnosis. Among these proteins, we recognized an immunodominant 44 kDa uncharacterized protein (A8GP63) that was not yet described in any Rickettsiae. It seems this protein has beta-barrel structures indicating outer membrane character which was proved by IFA. In addition, the protein shows significant immunoreactivity against the sera of patients with Rickettsialpox. Thus, the 44 kDa putative outer membrane protein (A8GP63) represents a good candidate for improved differential diagnosis of rickettsial diseases especially those caused by TRG of Rickettsia.

Methods

Bacterial growth and purification of R. akari

R. akari reference strain Hartford was propagated in egg yolk sacs of pathogen-free chicken embryos in BSL-3 containment as described previously [55] with some modifications. Briefly, 6 days old chicken embryos were inoculated and incubated at 35 °C. The bacterial inoculum was adjusted; therefore, most embryos died between 8 to 9 days after inoculation. Yolk sacs were collected, homogenized in 2 M NaCl solution and the suspension was centrifuged at 22000 x g at 4 °C. Pellet was resuspended in PBS and centrifuged again at low speed (200 x g for 10 min) to remove debris. The supernatant was then overlaid on 25% w/w sucrose cushion and centrifuged at 22000 x g at 4 °C. Resulted pellet was re-suspended in sucrose phosphate glutamate (SPG) buffer and purified by two rounds of Ultravist 370 (Bayer, Germany) discontinuous gradient centrifugation by using 32, 36, and 42% layers at 90000×g at 4 °C for 50 min. Light bands containing intact bacteria were collected, and centrifuged at 22000 x g for 30 min [55]. Finally, the pellet was re-suspended in PBS and stored at − 80 °C until analysis. Giménez staining technique was employed to evaluate the purity of rickettsial cells.

Gel-free proteomics

The bacterial cells of R. akari (4 mg/mL) were pelleted by centrifugation (18,000 x g; 20 min; 4 °C) and washed with 300 μl PBS. The resulting pellets were re-suspended in 100 μl of 50 mM Tris pH 7.5 containing 0.1% RapiGestTM SF (Waters, UK) [56] and then incubated for 10 min at 95 °C. After cooling, 200 μl of 0.1% RapiGestTM SF in 8 M guanidinium chloride (Sigma-Aldrich, USA) was added and incubated for another 20 min. Then, filter aided sample preparation – (FASP) [57] protocol was applied. Briefly, inactivated samples were transferred onto Amicon® Ultra – 10 kDa filters (Millipore) and washed twice with 100 mM ammonium bicarbonate (Sigma-Aldrich). Subsequently, proteins were quantified by bicinchoninic acid assay (QuantiPro™ BCA Assay Kit, Sigma-Aldrich) [58]. The samples were then reduced with 100 mM Tris (2-carboxyethyl) phosphine hydrochloride (TCEP, Sigma-Aldrich) and alkylated with 300 mM iodoacetamide (Sigma-Aldrich). Finally, the samples were digested with 2 μg of sequencing grade trypsin (Promega) overnight at 37 °C. Empore™ SPE Cartridges, C18, standard density, bed I.D. 4 mm (Sigma-Aldrich) were used to desalt peptide mixtures before drying to completion in a speed-vac. Prior to mass spectrometry analysis, the samples were re-suspended in 30 μl of 2% acetonitrile (ACN)/0.1% trifluoroacetic acid.

The samples were further analyzed by Ultimate 3000 RSLCnano system controlled by Chromeleon software (Dionex, USA), involving targeted mass spectrometry and LFQ as described earlier [59] with some modifications. Briefly, extracted peptide mixtures were loaded onto a PepMap100 C18, 3 μm, 100 Å, 0.075 × 20 mm trap column (Dionex) at 5 μl/min for 5 min. Separation was performed on a PepMap RSLC C18 column (0.075 × 150 mm, particle size 2.0 μm; Dionex) using 68 min gradient of 4–34% mobile phase B (80% ACN, 0.1% FA) with mobile phase A (0.1% formic acid, FA) and 21 min gradient of 34–55% mobile phase B at flow rate of 0.3 μl/min. Eluted peptides were electrosprayed into a Q-Exactive mass spectrometer using a Nanospray Flex ion source (Thermo Scientific, Bremen, Germany) to obtain positive ion full-scan MS spectra in the range 350–1650 m/z.

Acquired raw files were further processed in MaxQuant (version 1.6.7.0) [60]. Andromeda search engine [61] software was applied to identify proteins against the Rickettsia akari strain Hartford databases downloaded from Uniprot (September 21st, 2019). Identifications were accepted if at least two distinct reliable peptides matched the protein sequence, or the sequence coverage achieved at least 15%. Relative quantification was performed using the default parameters of the MaxLFQ algorithm [62], with the minimum ratio count set to 2.

Protein preparation and 2-D electrophoresis (2-DE)

The rickettsial pellet (2 mg wet-weight) was re-suspended in 4 mL of lysis buffer [28 mM Tris-HCl, 22 mM Tris-base, 200 mM dithiothreitol (DTT, Promega, USA), 2% SDS, protease inhibitor] and incubated for 30 min at 4 °C under shaking. After incubation sample was boiled for 5 min at 100 °C and cooled down on the ice for 5 min, followed by incubation with benzonase nuclease (Sigma-Aldrich, USA) 1ul/mL during 1 h at room temperature. The supernatant was collected after centrifugation at 14000 x g for 20 min at 4 °C and proteins precipitated with an equal volume of chloroform, 5 volumes of methanol, and 3 volumes of MilliQ water was added prior centrifugation at 14000 x g for 5 min at 4 °C. After phase separation, the upper phase was discarded, the same volume of methanol was added and vortexed. The protein pellet was collected by centrifugation at 14000 x g for 20 min at 4 °C, dried with N2 and stored at − 80 °C. Samples were dissolved in lysis buffer (8 M urea, 2 M thiourea, 85 mM DTT, 2.5% Triton X-100) prior to rehydration.

The IPG strip (18 cm, pH 3–10 NL; GE Healthcare, USA) was rehydrated overnight with approx. 140 μg of total protein with 1.0% v/v IPG Buffer (GE Healthcare) and 0.001% bromophenol blue in buffer No.7. The isoelectric focusing (IEF) was carried out in the Ettan IPGphor 3 IEF System apparatus (GE Healthcare, USA). After IEF each IPG strip was incubated in equilibration buffer composed of 6 M urea, 2% SDS, 30% glycerol, 375 mM Tris-HCl (ph 8.8) in the presence of 1.0% DTT for 15 min, followed by equilibration for 15 min in 3.75% iodoacetamide (IAA, Sigma-Aldrich, USA) solution in the same equilibration buffer. Equilibrated strips were transferred onto 13% polyacrylamide gels to perform second dimension SDS-PAGE. After electrophoresis, gels were stained with Coomassie brilliant blue R-250 (Serva, Germany) and stored at 4 °C until spot excision and trypsin digestion.

In-gel peptide digestion and MS analysis

Protein spots were excised, transferred into 1.5 mL Eppendorf tubes and distained in 50 mM ammonium bicarbonate buffer containing 50% acetonitrile (ACN, Merck, Germany), reduced with 10 mM DTT in 100 mM ammonium bicarbonate, followed with alkylation in 50 mM IAA in 100 mM ammonium bicarbonate buffer [63]. Proteins were digested with porcine trypsin in 10 mM ammonium bicarbonate with 10% acetonitrile at 37 °C overnight. The enzymatic reaction was stopped with a 70% acetonitrile solution containing 1.0% trifluoroacetic acid (TFA, Merck, Germany), and peptides were subsequently extracted. Supernatants were concentrated on SpeedVac (Eppendorf, Germany) to a final volume of 20 μl and analyzed by automated nanoflow reverse-phase (RP) liquid chromatography coupled to a Q-TOF (quadrupole time-of-flight) Premier Electrospray Ionisation (ESI) tandem mass spectrometer (Waters, USA). Separation of peptides was carried out on RP column BEH 130 C18 (200 mm × 75 μm, particle size 1.7 μm; Waters) using a 60 min gradient elution of 5–40% acetonitrile with 0.1% (w/w) formic acid at a flow rate of 0.3 μl/min. Samples were nanosprayed at 3.4 kV capillary voltage to Q-TOF detector and spectra were recorded from alternate scans at low (4 eV) and high (20–40 eV ramp) collision energies to obtain full-scan mass in ion range 50–1950 m/z. Finally, the data were processed by ProteinLynx Global Server 3.0.3 (Waters) searching the UniProt database (https://www.uniprot.org/proteomes/UP000291740). For peak picking the following thresholds were applied: low energy 140 counts and high energy 30 counts. Precursors and fragment ions were coupled, using correlations of chromatographic elution profiles in low/high energy traces. Spectra were searched against the assembled Rickettsiaceae proteome database (downloaded on January 20th, 2019). Workflow parameters for the protein identification queries were: i) maximum one possible trypsin miscleavage; ii) a fixed carbamidomethyl cysteine, variable oxidized methionine and deamidated asparagine/glutamine; iii) the precursors and fragments mass tolerance was automatically determined by the software; iv) peptide matching was limited to less than 4% false discovery rate against the randomized database. Identifications were accepted if at least two distinct reliable peptides matched the protein sequence or the sequence coverage achieved at least 15%.

Membrane protein enrichment methods

The first method was based on the Triton X-114 phase separation [30]. Briefly, the purified R. akari cells were resuspended in Triton X-114 extraction solution (1% Triton X-114, 10 mM Tris pH 7.5, 5 mM EDTA) and incubated on rotating platform at 4 °C for 4 h. After the extraction¸ sample was centrifuged at 15000 x g at 4 °C for 15 min, resulting in cell debris containing pellet and supernatant. This supernatant was layered over a chilled sucrose cushion, incubated at 37 °C for 30 min, and centrifuged at 500 x g for 20 min at 30 °C to separate the lower detergent and the upper aqueous phase. The proteins from the Triton X-114 and aqueous fractions were precipitated in acetone at − 20 °C prior to separation.

As a second membrane enrichment technique, the cell surface biotinylation method was applied. Briefly, purified R. akari bacteria were labeled with Sulfo-NHS-LC-Biotin (Thermo Scientific, USA) and the biotinylated proteins were captured on streptavidin agarose resin (Thermo Scientific) as described previously [64]. The captured proteins were eluted from the streptavidin resin with a 5% solution of 2-mercaptoethanol-PBS at 30 °C for 30 min, repeated 3 times, and the eluted proteins were precipitated in acetone at − 20 °C overnight. All protein fractions were then dissolved in Laemmli sample buffer and subjected to SDS-PAGE on 12% polyacrylamide gel. The whole lane was cut and processed by in-gel trypsin digestion and analyzed by LC-MS/MS as described above.

Preparation of recombinant proteins

The genes groEL, dnaK and 44 kDa uncharacterized protein (locus: A1C_04610) were amplified from the genomic sequence of R. akari (GenBank accession number: CP000847) with groEL primer pairs, 5′- TATA-CCATGG (NcoI)-CAACAAAACTTATTAAACACG − 3′ and 5′- TATA-AGATCT (BglII)-GGAAATCCATACCGCCCATA − 3′ and dnaK primer pairs, 5′- TATA-CCATGG (NcoI)-GAAAAGTAATAGGTATTGACCTTGG − 3′ and 5′- TATA-AGATCT (BglII)-TCTTCTTCGCTACATCCTGAAAATCG − 3′ and 44 kDa uncharacterized protein (locus: A1C_04610) primer pairs, 5′- AG-CCATGG (NcoI)-GTAAATTAAATAAATTAAATTTAACTATTGC − 3′ and 5′- CTGCAG (PstI)-CTAAATCTAATTTTAACCCTGCTCTAA − 3′. Each PCR amplified products was inserted into the pEcoli-Cterm6xHN vector (Clontech, Takara Bio USA) and then competent E. coli BL21(DE3) (Novagen, Merck Bioscience) cells were transformed with each recombinant plasmid and cultivated in LB broth (Amresco, USA) with addition of carbenicillin (Sigma-Aldrich). Expression of recombinant proteins were induced with 0.1 mM isopropyl- βD-thiogalactopyranoside (IPTG, Bioline, UK) at OD600 = 0.5–0.6, overnight 25 °C under shaking.

Recombinant proteins were purified by a combination of two methods: in first-round E. coli pellets (200 mg wet-weight per each clone) were lysed and purified according to the manufacturer’s instruction with HisTalon buffer set (Clontech, USA) and using Talon Metal affinity resin (Clontech, USA). Additional purification of protein eluates was achieved with ÄKTA pure protein purification system (GE Healthcare, USA), using HisTrap FF crude (GE Healthcare, Sweden) 1 mL columns according to the manufacturer’s instruction. Elution was done with a gradient of 20 mM to 200 mM imidazole in a buffer of 20 mM sodium phosphate pH 7.4 containing 0.5 M NaCl. Concentrations of dialyzed protein eluates were determined by Pierce bicinchoninic acid assay kit (BCA, Thermo Scientific, USA) [58].

Human and animal sera

Possitive rabbit and BALB/c mice sera were prepared as described previously [27] with some small modifications. Briefly, 108 live Rickettsia akari cells were intraperitoneally administered into rabbit in two consequent steps 28 days away. On the other hand, 30 μg of purified 44 kDa recombinant protein mixed with complete Freund’s adjuvant were intraperitoneally administered into the mice, followed by booster immunization with the same dose of protein combined with incomplete Freund’s adjuvant on the 28th-day after priming dose. Blood samples from the both experiments were collected at the 7th day after the booster by cardiac puncture under general anesthesia with sodium thiopental (for mice 50 mg/kg and 20 mg/kg for rabbit). Mice were sacrified by cervical dislocation and the rabbit was euthanized by intravenose overdose (100 mg/kg) of sodium thiopental (VUAB pharma, Czech republic). All animal experiments were conducted in the experimental animal facility at Biomedical Research Center of the Slovak Academy of Sciences (BMC, SAS) in accordance with the European Directive 2010/63/EU on the protection of animals used for scientific purposes and were approved by the ethical committee of BMC, SAS. The IgG titers of animal sera were determined by ELISA using the corresponding antigen.

The sera of rickettsia positive patients, diagnosed base on clinical signs and ELISA, were obtained from the National Reference Centre for Rickettsioses (established by Regional Authority of Public Health in Banska Bystrica, Slovakia). Before the experiments, sera were verified by IFA using a panel of rickettsial antigens, including SFG rickettsiae (R. slovaca, R. conorii, R.helvetica, R. rickettsii), R. typhi and R. akari. IFA test was considered positive when the antibody titers achieved a cutoff of 1/128 for IgG and 1/64 for IgM. A fourfold and greater increase above cutoff was recorded for three sera against R. akari antigen with positive clinical signs for rickettsialpox and for two sera against R. slovaca. Two sera from healthy blood donors were obtained from the serum collection of the Department of Rickettsiology, Biomedical Research Center of SAS in Bratislava.

Serological analysis of R. akari antigen and recombinant proteins using western blot

R. akari proteins resolved by 2-DE were transferred (at 100 V/90 min) onto 0.45 μm PVDF membrane (Pall Life Sciences, USA) and blocked in 5% non-fat dried milk (Bio-Rad, USA) in PBS with 0.1% Tween-20 at 4 °C overnight. Membranes were incubated with a serum of rabbit infected with R. akari or serum from infected patients at 1:1000 dilutions. After incubation, the membranes were probed with horseradish peroxidase-conjugated polyclonal swine anti-rabbit (Dako Denmark A/S, 1:3000) or polyclonal rabbit anti-human IgG (Dako Denmark A/S, 1:3000) secondary antibody, respectively. Visualization was carried out with a method of enhanced chemiluminescence (ECL) [65].

In order to characterize the immunogenic properties of recombinant proteins, 16 μg of each purified proteins were resolved by 12% SDS PAGE gels and transferred to the PVDF membranes. Then, each membrane was sliced into 8 strips (containing approx. 2 μg of protein) and incubated separately with different sera from infected patients at 1:1000 dilutions. After incubation and repeated washings, the membrane strips were probed and visualized as described above.

Preparation of “pre-absorbed” serum against rickettsial 44 kDa protein

The absorption procedure was described by Zhang et al. [66] with minor modifications. E. coli BL 21DE3 overnight cultures in LB broth with a density of 108 cells/ml were centrifuged, washed twice and re-suspended in 100 μl of rickettsial 44 KDa protein mouse serum, incubated for 2 h at 37 °C and then overnight at 4 °C on a rotator. E. coli cells were centrifuged at 10000 x g for 30 min; the supernatant was collected and used for Immunofluorescence assay.

Dual fluorescence staining of R. akari and 44 kDa uncharacterized protein (A8GP63)

Purified R. akari cells on a coverslip were fixed and permeabilized as described earlier [67]. Rickettsial cells were washed three times in PBS (pH 7.2) containing 2% bovine serum albumin (BSA; mixtures, PBSA) and then blocked with 5% BSA in PBS for 1 h at 37 °C. After washing, bacterial cells were incubated with a “pre-absorbed” mouse anti-serum against 44 kDa hypothetical protein (1:100) diluted in 2% PBSA for 1 h at 37 °C. After washing, cells were incubated with goat anti-mouse IgG secondary antibody conjugated with Alexa fluor 488 (Life Technologies, USA) diluted 1:1000 in PBS containing 2% PBSA. The cells were washed three times with PBSA and blocked again with 5% BSA in PBS for 1 h at 37 °C. R. akari cells were then stained by using polyclonal rabbit antiserum against live R. akari diluted 1:200 and a goat anti-rabbit IgG conjugated with Rhodamine (Life technologies, USA) diluted 1:2000. After five times washing with PBS, the coverslip was dried and mounted with Vectashield (Vector Laboratories) and viewed with fluorescence microscopy (model Eclipse Ni, Nikon Japan).

Database use and in silico analyses

Prediction of membrane proteins was performed using four independent programs: signal peptide prediction of identified peptides was completed by the program SignalP-5.0 (http://www.cbs.dtu.dk/services/SignalP/) [68]. Predictions of the subcellular localization of identified proteins was performed by program PSORTb version 3.0.2 (https://www.psort.org/psortb/) [31] and SOSUI-GramN (http://harrier.nagahama-i-bio.ac.jp/sosui/sosuigramn/sosuigramn_submit.html) [32]. Prediction of beta-barrel outer membrane proteins was made by a hidden Markov model PRED-TMBB program (http://bioinformatics.biol.uoa.gr/PRED-TMBB/input.jsp) [33]. Homology of identified protein with other rickettsial proteins was compared using the Basic Local Alignment Search Tool (BLAST) (https://blast.ncbi.nlm.nih.gov/Blast.cgi) [69]. Protein classification into COGs functional classes was carried out using public database EggNOG v5.0 (http://eggnog5.embl.de/#/app/home) [70]. Analysis of the 44 kDa protein was submitted to the bcell program (http://tools.immuneepitope.org/bcell/) which predicts flexible linear B-cell epitopes. The sequence was submitted with a signal peptide and a threshold 0.35 [71].

Availability of data and materials

The LC-MS/MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al., 2019) partner repository with the dataset identifier PXD017762 and PXD018060 (https://www.ebi.ac.uk/pride/archive/login).

Abbreviations

2-DE:

Two-dimensional gel electrophoresis

ACN:

Acetonitrile

AG:

Ancestral group

ATP:

Adenosine triphosphate

BSL3:

Biosafety level 3

COG:

Clusters of Orthologous Groups

ESI-LC-MS/MS:

Electrospray Ionisation liquid chromatography coupled with tandem mass spectrometry

IPG:

Immobilized pH gradient

kDa:

Kilo Daltons

MW:

Molecular weight

Omp:

Outer membrane protein

pI :

Isoelectric point

PVDF:

Polyvinylidene fluoride

Sca:

Surface cell antigen

SEP:

Surface exposed protein

SFG:

Spotted fever group

SPG:

Sucrose phosphate glutamate

TG:

Typhus group

TRG:

Transitional group

References

  1. 1.

    Gillespie JJ, Beier MS, Rahman MS, Ammerman NC, Shallom JM, Purkayastha A, et al. Plasmids and Rickettsial evolution: insight from Rickettsia felis. PLoS One. 2007;2:1–17.

  2. 2.

    Merhej V, Angelakis E, Socolovschi C, Raoult D. Genotyping, evolution and epidemiological findings of Rickettsia species. Infect Genet Evol. 2014;25:122–37. https://doi.org/10.1016/j.meegid.2014.03.014.

    Article  PubMed  Google Scholar 

  3. 3.

    Merhej V, Raoult D. Rickettsial evolution in the light of comparative genomics. Biol Rev. 2011;86:379–405.

    PubMed  Google Scholar 

  4. 4.

    Gillespie JJ, Drisco TP, Verhoeve VI, Utsuki T, Husseneder C, Chouljenko VN, et al. Genomic diversification in strains of Rickettsia felis isolated from different arthropods. Genome Biol Evol. 2014;7:35–56.

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    Gillespie JJ, Williams K, Shukla M, Snyder EE, Nordberg EK, Ceraul SM, et al. Rickettsia phylogenomics: unwinding the intricacies of obligate intracellular life. PLoS One. 2008;3:21–7.

    Google Scholar 

  6. 6.

    Huebner R, Jellison W, Pomerantz C. Rickettsialpox-a newly recognized rickettsial disease. IV. Isolation of a rickettsia apparently identical with the causative agent of rickettsialpox from Allodermanyssus sanguineus. A rodent mite. Public Heal Rep. 1946;61:1677–82.

    CAS  Google Scholar 

  7. 7.

    Huebner R, Jellison W, CA. Rickettsialpox-a newly recognized rickettsial disease. V. Recovery of Rickettsia akari from a house mouse (Mus musculus). Public Heal Rep. 1947;62:777–80.

    CAS  Google Scholar 

  8. 8.

    Ogawa M, Takahashi M, Matsutani M, Takada N, Noda S, Saijo M. Obligate intracellular bacteria diversity in unfed Leptotrombidium scutellare larvae highlights novel bacterial endosymbionts of mites. Microbiol Immunol. 2020;64:1–9.

    CAS  PubMed  Google Scholar 

  9. 9.

    Jackson EB, Danauskas JX, Coale MC, Smadel JE. Recovery of Rickettsia akari from the korean vole Microtus fortis pelliceus. Am J Epidemiol. 1957;66:301–8.

    CAS  Google Scholar 

  10. 10.

    Huebner RJ, Stamps PAC. Rickettsialpox; a newly recognized rickettsial disease; isolation of the etiological agent. Public Heal Rep. 1946;61(45):1605–14.

    CAS  Google Scholar 

  11. 11.

    Radulovic S, Feng HM, Morovic M, Djelalija B, Popov V, Crocquet-Valdes P, et al. Isolation of Rickettsia akari from a patient in a region where mediterranean spotted fever is endemic. Clin Infect Dis. 1996;22:216–20.

    CAS  PubMed  Google Scholar 

  12. 12.

    Dzelalija B, Punda-Polic V, Medic A, Dobec M. Rickettsiae and rickettsial diseases in Croatia: implications for travel medicine. Travel Med Infect Dis. 2016;14:436–43.

    PubMed  Google Scholar 

  13. 13.

    Terzin A, Gaon J. Some viral and rickettsial infections in Bosnia and Herzegovina: a sero-epidemiological study. Bull World Heal Organ. 1956;15:299–316.

    Google Scholar 

  14. 14.

    Fan M-Y, Walker D, Yu S-R, Liu Q-H. Epidemiology and ecology of rickettsial diseases in the People’s republic of China. Rev Infect Dis. 1987;9:823–40.

    CAS  PubMed  Google Scholar 

  15. 15.

    Rose HM. The clinical manifestations and laboratory diagnosis of rickettsialpox. Ann Intern Med. 1949;31:871–83.

    CAS  PubMed  Google Scholar 

  16. 16.

    Fuller H, Murray E, Ayres J, Snyder J, Potash L. Studies of rickettsialpox. I. Recovery of the causative agent from house mice in Boston, Massachusetts. Am J Hyg. 1951;54:82–100.

    CAS  PubMed  Google Scholar 

  17. 17.

    Boyd AS. Rickettsialpox. Infect Dis Dermatol. 1997;15:313–8.

    CAS  Google Scholar 

  18. 18.

    Koss T, Carter EL, Grossman ME, Silvers DN, Rabinowitz AD, Singleton J, et al. Increased detection of Rickettsialpox in a New York City Hospital following the Anthrax outbreak of 2001: use of immunohistochemistry for the rapid confirmation of cases in an era of bioterrorism. Arch Dermatol. 2003;139:1545–52.

    PubMed  Google Scholar 

  19. 19.

    Bennett SG, Comer JA, Smith HM, Webb JP. Serologic evidence of a Rickettsia akari-like infection among wild-caught rodents in Orange County and humans in Los Angeles County, California. J Vector Ecol. 2007;32:198.

    PubMed  Google Scholar 

  20. 20.

    Hebert GA, Tzianabos T, Gamble WC, Chappell WA. Development and characterization of high-titered, group-specific fluorescent-antibody reagents for direct identification of rickettsiae in clinical specimens. J Clin Microbiol. 1980;11:503–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Blanc G, Ogata H, Robert C, Audic S, Suhre K, Vestris G, et al. Reductive genome evolution from the mother of Rickettsia. PLoS Genet. 2007;3:0103–14.

    CAS  Google Scholar 

  22. 22.

    Chao CC, Chelius D, Zhang T, Daggle L, Ching WM. Proteome analysis of Madrid E strain of Rickettsia prowazekii. Proteomics. 2004;4:1280–92.

    CAS  PubMed  Google Scholar 

  23. 23.

    Renesto P, Ogata H, Audic S, Claverie JM, Raoult D. Some lessons from Rickettsia genomics. FEMS Microbiol Rev. 2005;29:99–117.

    CAS  PubMed  Google Scholar 

  24. 24.

    Renesto P, Azza S, Dolla A, Fourquet P, Vestris G, Gorvel JP, et al. Proteome analysis of Rickettsia conorii by two-dimensional gel electrophoresis coupled with mass spectrometry. FEMS Microbiol Lett. 2005;245:231–8.

    CAS  PubMed  Google Scholar 

  25. 25.

    Ogawa M, Renesto P, Azza S, Moinier D, Fourquet P, Gorvel JP, et al. Proteomne analysis of Rickettsia felis highlights the expression profile of intracellular bacteria. Proteomics. 2007;7:1232–48.

    CAS  PubMed  Google Scholar 

  26. 26.

    Pornwiroon W, Bourchookarn A, Paddock CD, Macaluso KR. Proteomic analysis of Rickettsia parkeri strain Portsmouth. Infect Immun. 2009;77:5262–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Qi Y, Xiong X, Wang X, Duan C, Jia Y, Jiao J, et al. Proteome analysis and serological characterization of surface-exposed proteins of Rickettsia heilongjiangensis. PLoS One. 2013;8:1–13.

  28. 28.

    Pérez-Llarena FJ, Bou G. Proteomics as a tool for studying bacterial virulence and antimicrobial resistance. Front Microbiol. 2016:1–21.

  29. 29.

    Sahni SK, Rydkina E. Host-cell interactions with pathogenic Rickettsia species. Future Microbiol. 2009;4:323–39.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Wang L, Coppel RL. Triton X-114 phase partitioning for antigen characterization. Methods Mol Med. 2002;72:581–5.

    CAS  PubMed  Google Scholar 

  31. 31.

    Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, et al. PSORTb 3.0: Improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics. 2010;26:1608–15.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Imai K, Asakawa N, Tsuji T, Akazawa F, Ino A, Sonoyama M, et al. SOSUI-GramN: high performance prediction for sub-cellular localization of proteins in gram-negative bacteria. Bioinformation. 2008;2:417–21.

    PubMed  PubMed Central  Google Scholar 

  33. 33.

    Bagos PG, Liakopoulos TD, Spyropoulos IC, Hamodrakas SJ. A hidden Markov model method, capable of predicting and discriminating β-barrel outer membrane proteins. BMC Bioinformatics. 2004;5:1–13.

    Google Scholar 

  34. 34.

    Sears KT, Ceraul SM, Gillespie JJ, Allen ED, Popov VL, Ammerman NC, et al. Surface proteome analysis and characterization of surface cell antigen (Sca) or autotransporter family of Rickettsia typhi. PLoS Pathog. 2012;8:1–17.

  35. 35.

    Karkouri K, El KM, Armstrong N, Azza S, Fournier PE, Raoult D. Multi-omics analysis sheds light on the evolution and the intracellular lifestyle strategies of spotted fever group Rickettsia spp. Front Microbiol. 2017;8:1–16.

    Google Scholar 

  36. 36.

    Driscoll TP, Verhoeve VI, Guillotte ML, Lehman SS, Rennoll SA, Beier-Sexton M, et al. Wholly rickettsia! Reconstructed metabolic profile of the quintessential bacterial parasite of eukaryotic cells. MBio. 2017;8:1–27.

  37. 37.

    Coolbaugh JC, Progar JJ, Weiss E. Enzymatic activities of cell-free extracts of Rickettsia typhi. Infect Immun. 1976;14:298–305.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Sahni S, Narra H, Sahni A, Walker DH. Recent molecular insights into rickettsial pathogenesis and immunity. Future Microbiol. 2014;8:1265–88.

    Google Scholar 

  39. 39.

    Putman M, Van Veen HW, Konings WN. Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev. 2000;64:672–93.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Gillespie JJ, Phan IQH, Driscoll TP, Guillotte ML, Lehman SS, Rennoll-Bankert KE, et al. The rickettsia type IV secretion system: unrealized complexity mired by gene family expansion. Pathog Dis. 2016;74:1–13.

    Google Scholar 

  41. 41.

    Fronzes R, Christie PJ, Waksman G. The structural biology of type IV secretion systems. Nat Rev Microbiol. 2009;7:703–14.

    CAS  PubMed  Google Scholar 

  42. 42.

    Chan YGY, Riley SP. Martinez JJ, Adherence to and invasion of host cells by spotted fever group Rickettsia species. Front Microbiol. 2010;1:1–10.

  43. 43.

    Blanc G, Ngwamidiba M, Ogata H, Fournier PE, Claverie JM, Raoult D. Molecular evolution of Rickettsia surface antigens: evidence of positive selection. Mol Biol Evol. 2005;22:2073–83.

    CAS  PubMed  Google Scholar 

  44. 44.

    Uchiyama T, Kawano H, Kusuhara Y. The major outer membrane protein rOmpB of spotted fever group rickettsiae functions in the rickettsial adherence to and invasion of Vero cells. Microbes Infect. 2006;8:801–9.

    CAS  PubMed  Google Scholar 

  45. 45.

    Li H, Walker DH. rOmpA is a critical protein for the adhesion of Rickettsia rickettsii to host cells. Microb Pathog. 1998;24:289–98.

    CAS  PubMed  Google Scholar 

  46. 46.

    Chan YGY, Cardwell M, Hermanas T, Uchiyama T, Martinez JJ. Rickettsial outer-membrane protein B (rOmpB) mediates bacterial invasion through Ku70 in an actin, c-Cbl, Clathrin and Caveolin 2- dependent manner. Cell Microbiol. 2009;11:629–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. 47.

    Fournier PE, Roux V, Raoult D. Phylogenetic analysis of spotted fever group rickettsiae by study of the outer surface protein rOmpA. Int J Syst Bacteriol. 1998;48:839–49.

    CAS  PubMed  Google Scholar 

  48. 48.

    Dubuisson JF, Vianney A, Hugouvieux-Cotte-Pattat N, Lazzaroni JC. Tol-pal proteins are critical cell envelope components of Erwinia chrysanthemi affecting cell morphology and virulence. Microbiology. 2005;151:3337–47.

    CAS  PubMed  Google Scholar 

  49. 49.

    Heinzen RA. Rickettsial actin-based motility: behavior and involvement of cytoskeletal regulators. Ann N Y Acad Sci. 2003;990:535–47.

    CAS  PubMed  Google Scholar 

  50. 50.

    Reed SCO, Lamason RL, Risca VI, Abernathy E, Welch MD. Rickettsia actin-based motility occurs in distinct phases mediated by different actin Nucleators. Curr Biol. 2014;24:98–103.

    CAS  PubMed  Google Scholar 

  51. 51.

    Welch MD, Way M. Arp2 / 3-mediated actin-based motility : a tail of pathogen abuse. Cell Host Microbe. 2014;14:242–55.

    Google Scholar 

  52. 52.

    Gouin E, Egile C, Dehoux P, Villiers V, Adams J, Gertler F, et al. The RickA protein of Rickettsia conorii activates the Arp2/3 complex. Nature. 2004;427:457–61.

    CAS  PubMed  Google Scholar 

  53. 53.

    Ellison DW, Clark TR, Sturdevant DE, Virtaneva K, Hackstadt T. Limited transcriptional responses of Rickettsia rickettsii exposed to environmental stimuli. PLoS One. 2009;4:1–11.

  54. 54.

    Audia JP, Patton MC, Winkler HH. DNA microarray analysis of the heat shock transcriptome of the obligate intracytoplasmic pathogen Rickettsia prowazekii. Appl Environ Microbiol. 2008;74:7809–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. 55.

    McLeod MP, Qin X, Karpathy SE, Gioia J, Highlander SK, Fox GE, et al. Complete genome sequence of Rickettsia typhi and comparison with sequences of other rickettsiae. J Bacteriol. 2004;186:5842–55.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. 56.

    Yu YQ, Gilar M, Lee PJ, Bouvier ESP, Gebler JC. Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins. Anal Chem. 2003;75:6023–8.

    CAS  PubMed  Google Scholar 

  57. 57.

    Wiśniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359–62.

    PubMed  Google Scholar 

  58. 58.

    Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76–85.

    CAS  PubMed  Google Scholar 

  59. 59.

    Dresler J, Klimentova J, Pajer P, Salovska B, Fucikova AM, Chmel M, et al. Quantitative Proteome Profiling of Coxiella burnetii Reveals Major Metabolic and Stress Differences Under Axenic and Cell Culture Cultivation. Front Microbiol. 2019;10:1–13.

  60. 60.

    Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367–72.

    CAS  PubMed  Google Scholar 

  61. 61.

    Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011;10:1794–805.

    CAS  PubMed  Google Scholar 

  62. 62.

    Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics. 2014;13:2513–26.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. 63.

    Shevchenko A, Tomas H, Havliš J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2007;1:2856–60.

    Google Scholar 

  64. 64.

    Ge Y, Rikihisa Y. Surface-exposed proteins of Ehrlichia chaffeensis. Infect Immun. 2007;75:3833–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. 65.

    Mruk DD, Cheng CY. Enhanced chemiluminescence (ECL) for routine immunoblotting. Spermatogenesis. 2011;1:121–2.

    PubMed  PubMed Central  Google Scholar 

  66. 66.

    Zhang W, Liu G, Tang F, Shao J, Lu Y, Bao Y, et al. Pre-absorbed immunoproteomics: a novel method for the detection of Streptococcus suis surface proteins. PLoS One. 2011;6.

  67. 67.

    Valáriková J, Sekeyová Z, Škultéty L, Bohácsová M, Quevedo-Diaz M. New way of purification of pathogenic Rickettsiae reducing health risks. Acta Virol. 2016;60:206–10.

    PubMed  Google Scholar 

  68. 68.

    Nielsen H, Tsirigos KD, Brunak S, von Heijne G. A brief history of protein sorting prediction. Protein J. 2019;38:200–16. https://doi.org/10.1007/s10930-019-09838-3.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  69. 69.

    Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403–410.

  70. 70.

    Huerta-Cepas J, Szklarczyk D, Heller D, Hernández-Plaza A, Forslund SK, Cook H, et al. EggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses. Nucleic Acids Res. 2019;47:D309–14.

    CAS  PubMed  Google Scholar 

  71. 71.

    El-Manzalawy Y, Dobbs D, Honavar V. Predicting flexible length linear B-cell epitopes. Comput Syst Bioinformatics Conf. 2008;7:121–32.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors thank Jana Vierikova for devoted technical support and Radivojka Banova for precious advice and help.

Funding

This study was supported by the grants from the Scientific Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences (VEGA-2/0057/19, VEGA-2/0068/18, 2/0052/19) and the Slovak Research and Development Agency (APVV 19–0066 and APVV 19–0519). Gel free proteomics experiments were funded from the grant of Ministry of Interior, Czech Republic, [VH20172020012: Preparation of the collection of biologically significant toxins with the support of European biological European biodefence laboratory network], the grant of Ministry of Defence of the Czech Republic through a Long-term organization development plan 907930101413, and the grant of Ministry of Education, Youth and Sports of the Czech Republic (L01509).

Author information

Affiliations

  1. Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Dúbravská cesta 9, 845 05, Bratislava, Slovak Republic

    František Csicsay, Gabriela Flores-Ramirez, Fernando Zuñiga-Navarrete, Mária Bartošová, Ľudovít Škultéty & Marco Quevedo-Diaz

  2. Department of Biology, Faculty of Science, University of Hradec Kralove, Hradecká 1285, 500 03, Hradec Králové, Czech Republic

    Alena Fučíková

  3. Military Health Institute, Military Medical Agency, Tychonova 1, CZ-160 00, Prague 6, Czech Republic

    Petr Pajer & Jiří Dresler

  4. Institute of Microbiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic

    Ľudovít Škultéty

Authors
  1. František Csicsay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriela Flores-Ramirez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fernando Zuñiga-Navarrete
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mária Bartošová
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alena Fučíková
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Petr Pajer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jiří Dresler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ľudovít Škultéty
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marco Quevedo-Diaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MQD and FC have designed and performed the biological experiments and wrote the manuscript. MB participated in recombinant protein preparation. AF and PP prepared proteomics samples. FZN and JD performed LC-MS/MS analyses; GFR interpreted MS data. LS coordinated the whole study. LS, MQD, and GFR revised the manuscript. All authors have read and approved the final version of the manuscript.

Corresponding authors

Correspondence to Ľudovít Škultéty or Marco Quevedo-Diaz.

Ethics declarations

Ethics approval and consent to participate

The usage of laboratory animals in the study was approved by the Ethical Committee of the Biomedical Research Center of the Slovak Academy of Sciences and the State Veterinary and Food Administration of the Slovak Republic under permission number: SK U 01016 292/16-221j. The experiments were accomplished under regular conditions in the experimental animal facility of the Biomedical Research Center of the Slovak Academy of Sciences. Laboratory animals used in this study were purchased from accredited breeding facility of the Department of Toxicology and Laboratory animals breeding IEPT, CEM, Slovak Academy of Science.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1.

Identified R. akari proteins classified in the COGs functional category. * S - gel-free approach “Shotgun”; 2D - two dimensional electrophoresis; B - biotinylation; T- Triton X-114 phase partitioning.

Additional file 2.

R.akari predicted surface-exposed proteins classified in the COGs functional category.

Additional file 3.

Predicted B-cell epitopes of the 44 kDa uncharacterized protein (A8GP63). Threshold 0.35. The orientation of the peptide in the outer membrane is defined as out-faced to the external space, in-faced the internal lipid bilayer, and membrane-embedded in the outer membrane.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Csicsay, F., Flores-Ramirez, G., Zuñiga-Navarrete, F. et al. Proteomic analysis of Rickettsia akari proposes a 44 kDa-OMP as a potential biomarker for Rickettsialpox diagnosis. BMC Microbiol 20, 200 (2020). https://doi.org/10.1186/s12866-020-01877-6

Download citation

Keywords

  • Rickettsia akari
  • Rickettsialpox
  • Proteome
  • Surface-exposed proteins
  • Outer membrane proteins

BMC Microbiology

ISSN: 1471-2180

Contact us